Table 1.

Study of patient demographics in dose escalation of OrienX010.

Demographic	Number	Percentage
Age (years)
Median	56
Range	25–70
Sex
Male	5	56
Female	4	44
Race
Asian	9	100
Diagnosis
Breast cancer	2	22
Malignant thymoma	1	11
Melanoma	2	22
Rectal cancer	2	22
GIST	1	11
Squamous cell carcinoma	1	11
Prior therapy lines of systemic therapy
Median	2
Range	0–10